Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Ribonucleotide reductase R2 specific phosphorothioate oligonucleotide

EU orphan designation number: EU/3/08/542   
Active ingredient: Ribonucleotide reductase R2 specific phosphorothioate oligonucleotide
Indication: Treatment of acute myeloid leukaemia
Sponsor: Dr. Ulrich Granzer
Forst-Kasten-Strasse 9B, D-82152 Krailling, Deutschland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
15/05/2008 Centralised Orphan - Designation EMEA/OD/118/07 (2008)1884 of 08/05/2008